1360439-82-2

Upstream product

• 1360439-79-7 5-(3,4-dichlorophenyl)-8-methoxy-2,5-methano-2,3,4,5-tetrahydro-1H-benzo[c]azepine 
• 1360439-78-6 3-(3,4-dichlorophenyl)-1-(3-methoxybenzyl)pyrrolidin-3-ol 
• 1044766-85-9 1-(3-methoxybenzyl)pyrrolidin-3-ol 
• 358-23-6 trifluoromethylsulfonic anhydride 
• 1360439-80-0 5-(3,4-dichlorophenyl)-2,5-methano-2,3,4,5-tetrahydro-1H-benzo[c]azepin-8-ol 
• 591-31-1 3-methoxy-benzaldehyde 

Downstream Products

• 1360439-86-6 8-(2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)-5-(3,4-dichlorophenyl)-2,5-methano-2,3,4,5-tetrahydro-1H-benzo[c]azepine 
• 1360439-72-0 8-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(3,4-dichlorophenyl)-2,5-methano-2,3,4,5-tetrahydro-1H-benzo[c]azepine 

Relevant academic research and scientific papers

2,5-Methano- and 2,5-Ethano-Tetrahydrobenzazepine Derivatives And Use Thereof To Block Reuptake Of Norepinephrine, Dopamine, and Serotonin

The compounds of the present invention are represented by the following 2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives having formula (I): where the carbon atom designated * is in the R or S configuration when n is 1 and the substituents X and R1-R7 are as defined herein.